Showing results (541-550 of 626) with videos related to
Sort By:
Pageof 63
Human Mutation|June 4, 2021
Biallelic variants in RNU12 cause CDAGS syndromeChao Xing, Mohammed Kanchwala, Jonathan J Rios, et al.Physical Review Letters|February 5, 2013
Is γ-ray emission from novae affected by interference effects in the 18F(p,α)15O reaction?A M Laird, A Parikh, A St J Murphy, et al.Trials|March 1, 2017
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registriesLouise A A Gerbens, Aaron E Boyce, Dmitri Wall, et al.Allergy|January 24, 2024
Impact of climate change on atopic dermatitis: A review by the International Eczema CouncilSheng-Pei Wang, Nicholas Stefanovic, Raquel L Orfali, et al.Infection and Immunity|April 5, 2017
Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic DermatitisOrla M Fleury, Maeve A McAleer, Cécile Feuillie, et al.Dermatology and Therapy|February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.Investigative Ophthalmology & Visual Science|May 8, 2014
siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann's epithelial corneal dystrophyDavid G Courtney, Sarah D Atkinson, Edwin H A Allen, et al.European Journal of Medical Genetics|April 29, 2022
The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomasAndrea Diociaiuti, Eulalia Baselga, Laurence M Boon, et al.Journal of the American Academy of Dermatology|July 7, 2026
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis: Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension studyAlan D Irvine, Amy S Paller, Elaine C Siegfried, et al.The Journal of Allergy and Clinical Immunology|February 11, 2012
Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiencySanja Kezic, Gráinne M O'Regan, René Lutter, et al.Pageof 63